Arrowhead Pharmaceuticals
ARWR
#2150
Rank
$8.78 B
Marketcap
$62.70
Share price
8.76%
Change (1 day)
392.15%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): $0.35

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.35. an increase over its 2024 EPS that were of -$5.00.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-$0.01000-99.8%
2024-$5.00161.39%
2023-$1.9117.36%
2022-$1.6319.85%
2021-$1.3661.9%
2020-$0.84-216.67%
2019$0.72-210.77%
2018-$0.6538.3%
2017-$0.47-64.93%
2016-$1.34-16.25%
2015-$1.6028%
2014-$1.25-3.85%
2013-$1.30-31.58%
2012-$1.90331.82%
2011-$0.44-51.11%
2010-$0.90-79.07%
2009-$4.30-37.68%
2008-$6.90-16.87%
2007-$8.3038.33%
2006-$6.00122.22%
2005-$2.7042.11%
2004-$1.90533.33%
2003-$0.30-99.08%
2002-$32.4725%
2001-$25.9733.33%
2000-$19.48-120%
1999$97.40-400%
1998-$32.47-81.48%
1997-$175.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$11.14 3,082.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-$7.27-2,177.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$6.30 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$1.80 414.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-$2.88-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA